Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Two-part prodrug system activates immune attack only in tumor's unique environment

2.

After all, Pulled Myeloma Drug May Help Treat the Illness.

3.

Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL

4.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

5.

No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot